Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
After leading AstraZeneca's Oncology areas nationally and internationally, Laura Colón will assume the presidency of AstraZeneca in one of its priority global markets
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Advancing toward Phase 2a evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track designation
Subscribe To Our Newsletter & Stay Updated